Last week the Food and Drug Administration approved the marketing of a 23-and-me, a test previously marketed as a way to trace ancestry, for screening individual’s genetic predisposition to certain medical diseases or conditions.

At first glance it might make sense. Screening to know one’s genetic profile for a disease should be helpful, right?

Not so.…Read More »